Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide

Cancer Discovery
Jingjing SunPadmanee Sharma

Abstract

Effector and regulatory T cells (Treg) share multiple markers that make it difficult to discern differences in these populations in humans. The transcription factor FoxP3 has been shown to identify Tregs. However, the detection of FoxP3 requires cell permeabilization, thereby preventing isolation of viable Tregs. Subsequently, the extracellular marker CD127 was established for the identification of Tregs. However, these studies were not conducted in the setting of immunotherapy. Here, we conducted studies to analyze CD127 and FoxP3 expression on T cells before and after in vitro activation as well as in the setting of patients treated with antibodies directed against cytotoxic T-lymphocyte antigen-4 (CTLA-4). We show that latency-associated peptide (LAP), as opposed to CD127, was capable of identifying Tregs after in vitro activation as well as after treatment with anti-CTLA-4. Therefore, we propose that LAP should be used as a marker of Tregs for immune monitoring studies in patients treated with active immunotherapy such as anti-CTLA-4. Tregs play an important role in human diseases, including cancer and autoimmunity; however, it has been difficult to study these cells because of a lack of an appropriate marker. Here, we prop...Continue Reading

References

Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Mar 22, 1996·Science·D R LeachJ P Allison
May 17, 2001·Molecular and Cellular Biochemistry·D A Lawrence
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Baecher-AllanD A Hafler
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kazuhiko NakamuraWarren Strober
Mar 23, 2006·Annual Review of Immunology·Steven F Ziegler
Aug 15, 2006·Immunological Reviews·David M Sansom, Lucy S K Walker
Dec 13, 2006·European Journal of Immunology·Jun WangRené E M Toes
Feb 3, 2007·Nature Immunology·Wen LinTalal A Chatila
Sep 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chrysoula I LiakouPadmanee Sharma
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hong ChenPadmanee Sharma
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dat Q TranEthan M Shevach
May 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bradley C CarthonPadmanee Sharma
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 16, 2010·Seminars in Oncology·Luana CalabròMichele Maio
Apr 15, 2011·Immunological Reviews·Sergio A QuezadaJames P Allison

❮ Previous
Next ❯

Citations

Mar 26, 2014·Expert Opinion on Biological Therapy·Belal ChaudharyEyad Elkord
Jun 18, 2014·Expert Opinion on Biological Therapy·Theresa L Whiteside
Nov 12, 2014·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Theresa L Whiteside
Nov 30, 2016·Nature Reviews. Urology·Hironobu YamashitaDavid J DeGraff
Feb 22, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amir H MassoudBruce D Mazer
Sep 8, 2015·Oncotarget·Eyad ElkordBelal Chaudhary
Dec 26, 2018·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Johannes NowatzkyOlivier Manches
Nov 28, 2019·Journal of Immunology Research·Na-Lin LaiXiao-Feng Li
Sep 27, 2018·Journal of Immunology Research·Sheng-Xiao ZhangXiao-Feng Li
May 16, 2012·Cancer Discovery·Sylvia M Lee, Cassian Yee
Oct 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick J SchulerTheresa L Whiteside

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.